SpaceX Puts the Wheels in Motion for Its IPO: 5 Reasons Why I Plan to Completely Avoid It

SpaceX confidentially filed for a U.S. IPO reportedly targeting a ~$1.75 trillion valuation and $50–$75 billion in proceeds, while Reuters cites roughly $15–16B in revenue and ~ $8B in profit last year. The author flags that the implied valuation equates to a triple‑digit P/E and >60x trailing sales and lists five risks: inflated valuation, Musk's history of overpromising, diluted/fragmented leadership, capital‑intensive execution risk (Starship/Starlink/xAI), and macro valuation headwinds given an elevated Shiller P/E. The recommendation is to avoid the IPO due to extreme premium pricing and heightened downside risk for richly valued debuts.

Analysis

A headline IPO from a conglomerate that bundles capital-intensive hardware, a consumer platform and an AI stack will reshuffle capital flows across both public and private markets. Expect concentrated primary issuance to force retail/intermediary participation decisions, creating two windows of volatility: immediate listing/lockup expiries (0–6 months) and subsequent dilution cycles tied to large capex milestones (12–36 months).

Second-order supply effects matter: a large integrated buyer of datacenter and edge compute will bid up specialized silicon and test/assembly capacity, compressing availability and raising lead-times for other hyperscalers over the next 6–18 months; silicon suppliers with flexible fabs can capture margin upside, while single-node dependent vendors will be squeezed. Satellite and launch-capable small caps face binary risk — any setback or missed bandwidth monetization will trigger outsized multiple compression because revenue scaling is lumpy and unit economics are fragile.

Corporate-governance and cross-ownership dynamics create systemic risk to sibling public assets. If management liquidity events or incentive structures transfer meaningful insider wealth into the new vehicle, expect increased volatility and potential underperformance in other listed equities connected to the same founder over a rolling 12-month window. Regulatory and geopolitical scrutiny of spectrum, export controls and data handling are high-probability catalysts that can flip multiple revenue streams from high-growth to constrained within quarters.

Near-term sentiment is likely over-euphoric; medium-term outcomes hinge on execution on two fronts — on-orbit service economics and profitable, repeatable AI inference margins. That dichotomy creates asymmetric trades where fee beneficiaries and equipment suppliers can be bought into structural tails, while pure-play competitors without diversified revenue visibility should be avoided or shorted around headline-led spikes.

Key Decisions for Investors

• Long NDAQ (6–12 months): buy Nasdaq (NDAQ) stock or 9–12 month calls to capture elevated listing and custody fee flow around large IPO activity. Target 20–30% upside if activity sustains; downside tied to a market-wide IPO freeze—limit position to 2–4% NAV.
• Short ASTS (immediate, 3 months): initiate a tactical short on ASTS with a protective stop at 20% adverse move. Thesis: small-cap satellite operators are high beta to program delays and will underperform; target 30–50% downside on catalytic missed launches or guidance cuts.
• Pair trade — short TSLA / long NVDA (6–12 months): short TSLA size 0.5–1x paired with long NVDA size 0.5–1x to express execution risk dilution versus secular AI upside. Expect asymmetric payoff if execution headlines depress auto multiples while AI spend sustains; put 15% stop on net exposure.
• Buy NVDA 3–6 month calls (or buy-and-hold small outright position): tactical long on NVDA to capture incremental datacenter demand from new AI entrants. Risk: semiconductor cycle pullback; size to ~1–2% NAV with defined premium at-risk.